CMD LSA branch endografts represent a valid solution for complex Zone 2 aortic pathology, offering full endovascular repair with individualized anatomical adaptation over off-the-shelf solutions. Our outcomes demonstrate early feasibility with high technical success; however, further studies with larger cohorts and long-term follow-ups are warranted.
Cambiaghi et al. (Sun,) studied this question.